Accelerating DeSci on Solana: Molecule, pump.science & BIO Protocol Team Up
pump.science & BIO are teaming up to power streamlined drug testing for BioDaos on Solana, starting with VitaDAO. Molecule is announcing the DeSci Ecosystem Grant w/ half its BIO token allocation.
Jillian Casalini
DeSci accelerated at lightspeed in 2024. Now, we are about to hit hyperdrive by bringing together two of the fastest-growing projects in DeSci on Solana.
Over the past few months, we have watched with excitement as BIO Protocol continued to put DeSci on the map — raising $45M in ETH and BioDAO tokens during BIO Genesis, securing strategic funding from Binance Labs, and readying the next wave of BioDAOs focused on chronically underfunded areas like Long COVID, Quantum Biology, and rare diseases. They've shown that decentralized communities of patients and researchers can unite onchain to advance early-stage R&D.
Meanwhile, we have been pushing boundaries with pump.science: turning longevity research into a spectator sport. By letting anyone speculate (speculator sports?) on longevity experiments, we've shown how memecoin tokenomics can be channeled to fund scientific research. In the first two months, pump.science has launched two compound tokens, streamed four experiments, and seen the first two tokens ($RIF and $URO) reach a combined market cap of $350M with over $1.5B in trading volume — showing the world the true power of stadium science.
Today, we're combining BIO’s BioDAO engine with pump.science’s experimental energy to hit hyperdrive, backed by three initiatives that will accelerate DeSci on Solana:
Our Commitment to DeSci on Solana
Strategic Partnership: BIO x pump.science
What happens when you combine BIO’s proven DAO machine with pump.science’s experiment protocol? Magic. We are looking at ways that BioDAOs can leverage pump.science for each of their research areas.
First up, pump.science is planning a collaboration with VitaDAO in early 2025 to stream longevity compounds submitted as part of the Longevity Prize and develop them into supplements, right on the platform. This will create a playbook for BioDAOs in the BIO Network to leverage pump.science for testing and validating IP in a transparent, community-driven way.
About the author
Jillian Casalini
I'm a biotech strategist and marketer with a foundation in traditional pharma and a vision for decentralized innovation. My career began in traditional pharma at Eli Lilly, where I learned how large-scale organizations bring rigor, regulation, and reach to life sciences. I also built a strong foundation in go-to-market strategy—bridging science with storytelling and turning complex research into clear, compelling narratives. That experience now fuels my passion for building at the intersection of biotech and decentralized science (DeSci)—where transparency, open collaboration, and new funding models are reshaping how research gets done.
Related Posts
Inside Molecule's Biggest Technical Evolution
Exploring the design decisions, new capabilities, and technical shifts powering Molecule's most transformative release to date.
Science IP Tokens /acc
Molecule’s original Science IP Token framework introduced a new primitive for science – a governance token linked directly to scientific IP.
Building the Hypothesis-to-IP Flywheel: BioAgents, ResearchHub & Molecule
In the early days of DeFi, growth exploded when builders started creating permissionless integrations around building blocks; collateralized debt positions, decentralized exchanges, lending protocols.